can i switch from tirzepatide to semaglutide A Comprehensive Guide for Smooth Transition What Happens When You Switch

Drug-induced hyponatremia associated with sodium-glucose cotransporter 2 inhibitors, immune checkpoint inhibitors, and targeted anticancer agents

The evidence doesnt confirm most severe risks, but careful monitoring and patient education are essential to maximize benefit and minimize harm

This dual effect makes GLP-1 receptor agonists effective for blood sugar regulation in diabetes and as weight loss medications

When Not to Use Eflornithine Known hypersensitivity to eflornithine or cream excipients Broken, inflamed, or infected skin in the application area Children ( 6 months: Continue maintenance if satisfied